Signed in
We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
| $240.87% | |
| $0.340.01% | |
| $0.210.01% | |
| $0.170.01% | |
| $0.080.00% | |
| $0.000.00% |
Lilly, $LLY, partners with OpenAI to develop medicines for drug-resistant bacteria